Related Experiment Videos
Rifampin activity against Staphylococcus epidermidis biofilms
G Obst1, R F Gagnon, J Prentis
1Department of Medicine, Montreal General Hospital, McGill University, Quebec, Canada.
ASAIO Transactions
|July 1, 1988
Summary
Rifampin effectively targets Staphylococcus epidermidis biofilms. Combining rifampin with vancomycin enhanced killing, while fresh peritoneal dialysis fluid boosted its antimicrobial effect.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcus epidermidis is a common cause of biofilm-related infections.
- Effective treatment of S. epidermidis biofilms remains a clinical challenge.
- Antibiotic efficacy can be influenced by the local microenvironment.
Purpose of the Study:
- To evaluate the antimicrobial activity of rifampin against Staphylococcus epidermidis biofilms.
- To assess the impact of antibiotic combinations and peritoneal dialysis solutions on rifampin efficacy.
Main Methods:
- In vitro testing of rifampin against S. epidermidis biofilms.
- Evaluation of combinations with clindamycin, gentamicin, tetracycline, and vancomycin.
- Assessment of the effect of fresh and spent peritoneal dialysis solutions.
Main Results:
- Rifampin demonstrated significant antimicrobial activity against S. epidermidis biofilms.
- Clindamycin, gentamicin, and tetracycline showed antagonism with rifampin.
- Vancomycin exhibited synergy with rifampin, achieving complete bacterial killing.
- Fresh peritoneal dialysis solution enhanced rifampin's activity, whereas spent solution neutralized it.
Conclusions:
- Rifampin is a promising agent for treating S. epidermidis biofilm infections.
- Combination therapy with vancomycin and the use of fresh peritoneal dialysis fluid may optimize treatment outcomes.